Drug · DIN 02229285
ZYPREXA
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since January 30, 2025; first marketed November 14, 1996.
- Drug Identification Number (DIN)
- 02229285
- Company (DIN owner)
- Cheplapharm Registration GmbhLörrach, Germany
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Olanzapine N05AH03
- Class
- Human
- Record last updated
- October 7, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| OLANZAPINE | 10 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- January 30, 2025: NOC 34770New Drug Submission (NDS) · Change in product ownership and Product Monograph reformatted to the Master Template
- October 28, 1996: NOC 4592New Drug Submission (NDS)
Other DINs named ZYPREXA
- DIN 02229250 · Marketed
- DIN 02229269 · Marketed
- DIN 02229277 · Marketed
- DIN 02238850 · Marketed
- DIN 02238851 · Marketed